On 2025-05-12, Black Diamond Therapeutics, Inc. (BDTX) announced earnings per share of $0.98 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $0.02.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.27 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $0.02 | $0.98 |
| 2025-03-06 | 2024-12-31 | $-0.31 | $-0.28 |
| 2024-11-05 | 2024-09-30 | $-0.37 | $-0.28 |
| 2024-08-06 | 2024-06-30 | $-0.39 | $-0.36 |
| 2024-05-09 | 2024-03-31 | $-0.44 | $-0.35 |
| 2024-03-12 | 2023-12-31 | $-0.47 | $-0.34 |
| 2023-11-06 | 2023-09-30 | $-0.49 | $-0.45 |
| 2023-08-11 | 2023-06-30 | $-0.54 | $-0.52 |
| 2023-05-09 | 2023-03-31 | $-0.61 | $-0.57 |
| 2023-03-09 | 2022-12-31 | $-0.63 | $-0.59 |
| 2022-11-08 | 2022-09-30 | $-0.64 | $-0.60 |
| 2022-08-09 | 2022-06-30 | $-0.68 | $-0.63 |
| 2022-05-11 | 2022-03-31 | $-0.75 | $-0.70 |
| 2022-03-17 | 2021-12-31 | $-1.01 | $-0.71 |
| 2021-11-08 | 2021-09-30 | $-0.98 | $-0.97 |
| 2021-08-12 | 2021-06-30 | $-0.87 | $-0.95 |
| 2021-05-07 | 2021-03-31 | $-0.67 | $-0.84 |
| 2021-03-25 | 2020-12-31 | $-0.63 | $-0.63 |
| 2020-11-10 | 2020-09-30 | $-0.53 | $-0.50 |
| 2020-08-11 | 2020-06-30 | $-0.43 | $-0.41 |
| 2020-05-12 | 2020-03-31 | $-0.47 | $-0.51 |
| 2020-03-24 | 2019-12-31 | $-1.37 | $-4.63 |